Day: April 30, 2025

KISSIMMEE, Fla., April 30, 2025 (GLOBE NEWSWIRE) — ECD Auto Design (NASDAQ: ECDA), the world’s leading creator of restored Land Rovers and custom classic vehicles, proudly debuts Project Beach Patrol, a Defender 90 soft top built for warm weather, relaxed cruising, and statement-making style—all handcrafted in the U.S.A. View images and video of Project Beach Patrol Finished in a vivid Land Rover AA Yellow gloss finish, Beach Patrol is a one-of-one open-air Defender built entirely at ECD’s 100,000-square-foot Florida facility. From its sleek black Optimil hardware to its powerful V8 heart, this Defender is engineered for long weekends, beach runs, and unforgettable coastal adventures. A Clean Coastal Statement Project Beach Patrol’s exterior is designed for head-turning simplicity. The vibrant yellow body is accented by...

Successfully demonstrates three days of continuous survey operations MONROE TOWNSHIP, N.J., April 30, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and more productive ocean operations and related power, data, and service solutions, today announced the shipment of a WAM-V® 22’ with autonomous capabilities designed to provide offshore surveys with 24/7 operational payloads for multiple days without requiring a return to base. This WAM-V® recently completed a successful demonstration, conducting a three day fully remote, continuous survey operation, while deploying a simulated survey payload. Philipp Stratmann, CEO of Ocean Power Technologies,...

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that TriStar Centennial Medical Center, through Sarah Cannon Research Institute (SCRI), in Nashville, Tennessee, is a clinical trial site for the Company’s Phase 1 clinical of CER-1236. Collaborating with SCRI to advance cancer research, TriStar Centennial offers innovative clinical research trials for various disease indications. The trial is focused on patients with acute myeloid leukemia (AML), and patient enrollment is underway, with expected dosing of the first patient during the first half of 2025.  Stephen Strickland, Jr., M.D., MSCI,...

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will provide a corporate update and participate in one-on-one investor meetings at the Citizens Life Sciences Conference, to be held in New York, NY May 7-8, 2025. Format: Corporate update and one-on-one investor meetingsDate: Wednesday, May 7, 2025Time: 10:00 a.m. ETLocation: New York, NYWebcast Link: Click Here About BioAtla®, Inc.BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through its contractual relationship with BioDuro-Sundia, a provider of preclinical development...

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: HW3 | OTCQB: GXPLF) is pleased to announce the completion of a high-resolution helicopter-borne Mobile MagnetoTellurics System (“MobileMT”) survey at the Sabre Uranium Project (the “Sabre Property” or the “Project”) located in the northern Athabasca Basin region of Saskatchewan, Canada. The Project-wide MobileMT survey completed by Expert Geophysics Surveys Inc. (“EGS”) consisted of 1,536 line-kilometres flown at 200-metre line spacings over a 232 square kilometre area. The MobileMT survey was implemented to map sub-surface magnetic signatures and detect conductive zones within the margin of the Athabasca Basin sandstones that may be prospective for hosting unconformity-related uranium mineralization.Figure...

CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, President and CEO, will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, May 7, at 12:30 pm ET. A live webcast of the fireside chat will be available on the Events page of the Investors section of the Company website or by clicking here. The webcast replay will be archived for 30 days on the Events page. Institutional investors interested in meeting with management during the conference may reach out to their Citizens representative. About Solid BiosciencesSolid Biosciences is a precision genetic medicine company focused on advancing a portfolio of...

Preliminary Geomicrobial Results Uncovers Promising Microbial Signatures Linked to Rare Earth Potential CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce preliminary results from its 2024 geomicrobial survey at the Burntwood Project in northern Manitoba, where early findings demonstrate promising microbial patterns that may serve as biological pathfinders for rare earth element (REE) mineralization associated with carbonatite intrusions. The survey covered the northern extent of the Burntwood Syenite-Carbonatite Complex, a regional intrusive system considered prospective for REE and other critical metals. A total of 808 unique soil samples were collected and analyzed using 16S rRNA and metagenomic sequencing, with sampling...

PETAH-TIKVA, Israel, April 30, 2025 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the first quarter ended March 31, 2025, before market open on Wednesday, May 14, 2025. Global-e management will host a conference call to review its financial results and outlook.Date: Wednesday, May 14, 2025Time: 8:00 AM ETUnited States/Canada Toll Free: +1-800-717-1738International Toll: +1-646-307-1865   Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Global-e’s website at https://investors.global-e.com/news-events/events-presentations A replay of the webcast will be available in the Investor...